Xintao Shuai Selected Research

Inflammation (Inflammations)

7/2023	Stiffness-tuned and ROS-sensitive hydrogel incorporating complement C5a receptor antagonist modulates antibacterial activity of macrophages for periodontitis treatment.
1/2023	MRI-visible mesoporous polydopamine nanoparticles with enhanced antioxidant capacity for osteoarthritis therapy.
10/2020	Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways.
10/2018	Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation.
1/2018	Sulfated zwitterionic poly(sulfobetaine methacrylate) hydrogels promote complete skin regeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xintao Shuai Research Topics

Disease

104	Neoplasms (Cancer) 04/2024 - 06/2005
13	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 02/2011
12	Neoplasm Metastasis (Metastasis) 03/2024 - 04/2016
11	Breast Neoplasms (Breast Cancer) 04/2024 - 08/2004
10	Hypoxia (Hypoxemia) 02/2024 - 08/2019
8	Triple Negative Breast Neoplasms 04/2024 - 11/2021
7	Glioma (Gliomas) 12/2020 - 02/2012
6	Carcinoma (Carcinomatosis) 01/2014 - 10/2008
5	Inflammation (Inflammations) 07/2023 - 01/2018
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2014
5	Hyperthermia 01/2023 - 12/2017
5	Stroke (Strokes) 12/2022 - 05/2014
4	Bites and Stings (Sting) 01/2023 - 01/2023
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 05/2009
4	Ischemic Stroke 12/2022 - 12/2016
4	Stomach Neoplasms (Stomach Cancer) 08/2013 - 03/2010
3	Colonic Neoplasms (Colon Cancer) 03/2024 - 01/2021
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 08/2013
2	Adenocarcinoma 10/2023 - 01/2023
2	Fibrosis (Cirrhosis) 09/2021 - 03/2019
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2020
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2020
2	Atherosclerosis 09/2019 - 10/2018
2	Neuroblastoma 01/2018 - 01/2012
2	Wounds and Injuries (Trauma) 01/2018 - 09/2014
2	Liver Neoplasms (Liver Cancer) 06/2016 - 03/2011
2	Ovarian Neoplasms (Ovarian Cancer) 07/2014 - 01/2012

Drug/Important Bio-Agent (IBA)

34	Small Interfering RNA (siRNA)IBA 10/2023 - 01/2006
20	MicellesIBA 03/2021 - 08/2004
14	Therapeutic UsesIBA 12/2022 - 02/2012
14	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2020 - 12/2011
12	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
11	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 10/2018
10	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2023 - 01/2018
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2006
8	Liposomes (Liposome)IBA 01/2023 - 06/2013
8	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2023 - 03/2010
7	Photosensitizing Agents (Photosensitizers)IBA 02/2024 - 08/2020
7	ferric oxide (iron oxide)IBA 10/2020 - 10/2008
7	PolyethyleneimineIBA 10/2017 - 03/2010
6	Oxygen (Dioxygen)IBA 12/2023 - 08/2019
6	polydopamineIBA 12/2023 - 08/2020
6	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018 - 07/2008
5	LigandsIBA 03/2023 - 03/2011
5	phytochlorinIBA 01/2023 - 01/2020
5	Contrast MediaIBA 06/2022 - 05/2009
5	PolymersIBA 07/2021 - 01/2006
4	EnzymesIBA 04/2024 - 01/2019
4	AntigensIBA 03/2023 - 08/2013
4	Peptides (Polypeptides)IBA 01/2023 - 10/2019
4	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 11/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2014
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2024 - 01/2019
3	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 12/2023 - 08/2020
3	HydrogelsIBA 07/2023 - 01/2018
3	Glutathione (Reduced Glutathione)IBA 01/2023 - 08/2019
3	Metal-Organic FrameworksIBA 09/2022 - 01/2020
3	Menthol FDA Link 01/2022 - 01/2019
3	Caspase 3 (Caspase-3)IBA 01/2020 - 02/2012
3	GoldIBA 01/2019 - 02/2016
3	Antineoplastic Agents (Antineoplastics)IBA 07/2016 - 10/2008
3	Messenger RNA (mRNA)IBA 01/2014 - 03/2011
2	CatalaseIBA 12/2023 - 08/2020
2	Glucose OxidaseIBA 12/2023 - 10/2021
2	AntibodiesIBA 10/2023 - 01/2023
2	Mannose (D-Mannose)IBA 03/2023 - 01/2023
2	perflexane (perfluorohexane)FDA Link 01/2023 - 07/2021
2	B7-H1 AntigenIBA 01/2023 - 01/2022
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2023 - 07/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2011
2	Hydroxyl RadicalIBA 01/2023 - 10/2021
2	CalreticulinIBA 01/2023 - 01/2021
2	DisulfidesIBA 01/2023 - 08/2019
2	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 01/2023 - 09/2020
2	InterferonsIBA 01/2023 - 01/2023
2	NanovaccinesIBA 01/2023 - 01/2022
2	ProdrugsIBA 09/2022 - 07/2021
2	Phosphates (Orthophosphate)IBA 12/2021 - 01/2002
2	IronIBA 10/2021 - 10/2020
2	Sunitinib (Sutent)FDA Link 01/2020 - 01/2019
2	monomethoxypolyethylene glycol (MPEG)IBA 09/2019 - 05/2014
2	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 09/2019 - 08/2019
2	FluorocarbonsIBA 01/2019 - 01/2018
2	Coloring Agents (Dyes)IBA 01/2019 - 12/2013
2	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 01/2014
2	Prostaglandins AIBA 06/2016 - 03/2011
2	RNA (Ribonucleic Acid)IBA 05/2016 - 05/2014
2	SolutionsIBA 02/2014 - 01/2002
2	ArsenicIBA 02/2014 - 08/2013

Therapy/Procedure

67	Therapeutics 04/2024 - 01/2006
25	Drug Therapy (Chemotherapy) 09/2022 - 07/2008
23	Immunotherapy 04/2024 - 08/2019
16	Lasers (Laser) 04/2024 - 05/2010
13	Photothermal Therapy 12/2023 - 12/2013
10	Photochemotherapy (Photodynamic Therapy) 02/2024 - 01/2020
10	Precision Medicine 01/2023 - 12/2013
6	Transplantation 12/2022 - 05/2014
4	Microbubbles 02/2024 - 01/2018
2	Nanospheres 12/2023 - 01/2019
2	Liver Transplantation 09/2021 - 04/2016